These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 663942)

  • 1. Toxicologic studies of N-trichloromethylthio-4-cyclohexene-1,2-dicarboximide (captan): its metabolism by rat liver drug-metabolizing enzyme system.
    Peeples A; Dalvi RR
    Toxicology; 1978 Apr; 9(4):341-51. PubMed ID: 663942
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Involvement of glutathione in the reduction of captan-induced in vivo inhibition of monooxygenases and liver toxicity in the rat.
    Dalvi RR
    J Environ Sci Health B; 1988 Apr; 23(2):171-8. PubMed ID: 3385136
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of muroctasin on the activities of drug metabolizing enzymes in liver microsomes of rats.
    Kamataki T; Komori M; Iwasaki M; Ohi H; Kitada M; Miura T; Ono K
    Arzneimittelforschung; 1988 Jul; 38(7A):1019-22. PubMed ID: 3263867
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of the oral contraceptive, menstranol, on drug-metabolizing enzymes of female rats in thiamin-supplemented and deficiency states.
    Wade AE; Evans JL; Seitz A
    Pharmacology; 1976; 14(2):104-14. PubMed ID: 822434
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of norethindrone on drug-metabolizing enzymes of female rat liver in various B-vitamin deficiency states.
    Wade AE; Evans JS
    Pharmacology; 1977; 15(4):289-301. PubMed ID: 408827
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lack of in vitro and in vitro effects of fenbendazole on phase I and phase II biotransformation enzymes in rats, mice and chickens.
    Dalvi RR; Gawai KR; Dalvi PS
    Vet Hum Toxicol; 1991 Dec; 33(6):548-51. PubMed ID: 1808827
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of chronic ethanol administration in the rat: relative dependency on dietary lipids. II. Paradoxical role of linoleate in the induction of hepatic drug-metabolizing enzymes in vitro.
    Joly JG; Hétu C
    Can J Physiol Pharmacol; 1977 Feb; 55(1):34-41. PubMed ID: 402995
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Toxicological implications of the mixed-function oxidase catalyzed metabolism of carbon disulfide.
    Dalvi RR; HUNTER AL; Neal RA
    Chem Biol Interact; 1975 May; 10(5):347-61. PubMed ID: 237636
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cadmium administration and hepatic drug metabolizing enzyme system: effect of pretreatment with phenobarbital and 3-methyl cholanthrene.
    Mgbodile MU
    Biochem Int; 1983 Jan; 6(1):11-20. PubMed ID: 6679315
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mixed-function oxidase system induction and propylene hepatotoxicity.
    Osimitz TG; Conolly RB
    J Toxicol Environ Health; 1985; 15(1):39-49. PubMed ID: 2984438
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of methylxanthines on aniline disappearance and metabolism in rats.
    Aeschbacher HU
    Experientia; 1975 Aug; 31(8):894-6. PubMed ID: 1157848
    [No Abstract]   [Full Text] [Related]  

  • 12. Interaction of parathion and malathion with hepatic cytochrome P-450 from rats treated with phenobarbital and carbon disulfide.
    Dalvi RR; Howell CD
    Drug Chem Toxicol; 1978; 1(2):191-202. PubMed ID: 755667
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protection by Osbeckia aspera against carbon tetrachloride-mediated alterations in microsomal drug metabolizing enzyme activity.
    Jayatilaka KA; Thabrew MI
    J Pharm Pharmacol; 2000 Apr; 52(4):461-5. PubMed ID: 10813559
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acute effect of cadmium on hepatic drug-metabolizing enzymes in the rat.
    Teare FW; Jasansky P; Renaud L; Read PR
    Toxicol Appl Pharmacol; 1977 Jul; 41(1):57-65. PubMed ID: 898191
    [No Abstract]   [Full Text] [Related]  

  • 15. Influence of dietary thiamin on phenobarbital induction of rat hepatic enzymes responsible for metabolizing drugs and carcinogens.
    Wade AE; Evans JS; Holmes D; Baker MT
    Drug Nutr Interact; 1983; 2(2):117-30. PubMed ID: 6432511
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protective effect of glutathione on the in vitro inhibition of hepatic cytochrome P-450 by captan.
    Dalvi RR; Ashley WM
    Drug Chem Toxicol; 1979; 2(3):245-55. PubMed ID: 121071
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effect of thiamine on the activity of liver endoplasmic reticulum enzymes metabolizing drugs].
    Sushko LI; Lukienko PI
    Farmakol Toksikol; 1979; 42(1):56-9. PubMed ID: 421893
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biotransformation of N,N',N''-triethylenethiophosphoramide: oxidative desulfuration to yield N,N',N''-triethylenephosphoramide associated with suicide inactivation of a phenobarbital-inducible hepatic P-450 monooxygenase.
    Ng SF; Waxman DJ
    Cancer Res; 1990 Feb; 50(3):464-71. PubMed ID: 2105156
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Induction of cytochrome P-450 and related drug-oxidizing activities in muscone (3-methylcyclopentadecanone)-treated rats.
    Tanaka E; Kurata N; Kohno M; Yoshida T; Kuroiwa Y
    Biochem Pharmacol; 1987 Dec; 36(24):4263-7. PubMed ID: 3689452
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of chronic ethanol administration in the rat: relative dependency on dietary lipids--I. Induction of hepatic drug-metabolizing enzymes in vitro.
    Joly JG; Hétu C
    Biochem Pharmacol; 1975 Aug; 24(16):1475-80. PubMed ID: 811224
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.